Long noncoding RNA H19-derived miR-675 aggravates restenosis by targeting PTEN

Biochemical and Biophysical Research Communications

Volumn 497, Issue 4, 2018, Pages 1154-1161

  Lv, Junyuan ^a   Wang, Lei ^a   Zhang, Jin ^a   Lin, Ruoran ^a   Wang, Lun ^a   Sun, Weifeng ^a   Wu, Huize ^a   Xin, Shijie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

H19; miR 675; Noncoding RNAs; Restenosis; Vascular smooth muscle cells

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 675; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RNA H19; UNCLASSIFIED DRUG; H19 LONG NON-CODING RNA; PTEN PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY INJURY; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE EXACERBATION; EMBRYO; EXPERIMENTAL BALLOON CATHETER INJURY; GENE FUNCTION; GENE OVEREXPRESSION; HA VSMC CELL LINE; HEK293T CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTIMA; LUCIFERASE ASSAY; MALE; NONHUMAN; PRIORITY JOURNAL; PTEN GENE; RAT; RESTENOSIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL LINE; SPRAGUE DAWLEY RAT; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; CYTOLOGY; GENETICS; GRAFT OCCLUSION; PATHOLOGY; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ANIMALS; CAROTID ARTERY INJURIES; CELL PROLIFERATION; GRAFT OCCLUSION, VASCULAR; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; PTEN PHOSPHOHYDROLASE; RATS; RNA, LONG NONCODING;

EID: 85019761011     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2017.01.011     Document Type: Article

References (32)

1. Setacci, C., Castelli, P., Chiesa, R., Grego, F., Simoni, G.A., Stella, A., Galzerano, G., Sirignano, P., De Donato, G., Setacci, F., Restenosis: a challenge for vascular surgeon. J. Cardiovasc Surg. (Torino) 53 (2012), 735–746.
2. Chan, P., Munro, E., Patel, M., Betteridge, L., Schachter, M., Sever, P., Wolfe, J., Cellular biology of human intimal hyperplastic stenosis. Eur. J. Vasc. Surg. 7 (1993), 129–135.
3. Er, O.B., Ma, X., Simard, T., Pourdjabbar, A., Hibbert, B., Pathogenesis of neointima formation following vascular injury. Cardiovasc Hematol. Disord. Drug Targets 11 (2011), 30–39.
4. Li, F., Duman-Scheel, M., Yang, D., Du, W., Zhang, J., Zhao, C., Qin, L., Xin, S., Sonic hedgehog signaling induces vascular smooth muscle cell proliferation via induction of the G1 cyclin-retinoblastoma axis. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 1787–1794.
5. Pober, J.S., Jane-wit, D., Qin, L., Tellides, G., Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 1609–1614.
6. Gareri, C., De Rosa, S., Indolfi, C., MicroRNAs for restenosis and thrombosis after vascular injury. Circ. Res. 118 (2016), 1170–1184.
7. Liang, M., Liang, A., Wang, Y., Jiang, J., Cheng, J., Smooth muscle cells from the anastomosed artery are the major precursors for neointima formation in both artery and vein grafts. Basic Res. Cardiol., 109, 2014, 431.
8. Thum, T., Condorelli, G., Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circ. Res. 116 (2015), 751–762.
9. Kim, D.K., Zhang, L., Dzau, V.J., Pratt, R.E., H19, a developmentally regulated gene, is reexpressed in rat vascular smooth muscle cells after injury. J. Clin. Investig. 93 (1994), 355–360.
10. Cai, X., Cullen, B.R., The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA 13 (2007), 313–316.
11. Vennin, C., Spruyt, N., Dahmani, F., Julien, S., Bertucci, F., Finetti, P., Chassat, T., Bourette, R.P., Le Bourhis, X., Adriaenssens, E., H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Oncotarget 6 (2015), 29209–29223.
12. Liu, G., Xiang, T., Wu, Q.F., Wang, W.X., Long noncoding RNA H19-Derived miR-675 enhances proliferation and invasion via RUNX1 in gastric cancer cells. Oncol. Res. 23 (2016), 99–107.
13. N.R.C.C.f.t.U.o.t.G.f.t. Care, U.o.L. Animals, Guide for the Care and Use of Laboratory Animals, Guide for the Care & Use of Laboratory Animals, vol. 327, 2011, 41–48.
14. Miltenburger, H.G., Sachse, G., Schliermann, M., S-phase cell detection with a monoclonal antibody. Dev. Biol. Stand 66 (1987), 91–99.
15. Rehmsmeier, M., Steffen, P., Hochsmann, M., Giegerich, R., Fast and effective prediction of microRNA/target duplexes. RNA 10 (2004), 1507–1517.
16. Paraskevopoulou, M.D., Georgakilas, G., Kostoulas, N., Vlachos, I.S., Vergoulis, T., Reczko, M., Filippidis, C., Dalamagas, T., Hatzigeorgiou, A.G., DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res. 41 (2013), W169–W173.
17. Jia, H., Osak, M., Bogu, G.K., Stanton, L.W., Johnson, R., Lipovich, L., Genome-wide computational identification and manual annotation of human long noncoding RNA genes. RNA 16 (2010), 1478–1487.
18. Pachnis, V., Belayew, A., Tilghman, S.M., Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes. Proc. Natl. Acad. Sci. U. S. A 81 (1984), 5523–5527.
19. Zhang, Y., Tycko, B., Monoallelic expression of the human H19 gene. Nat. Genet. 1 (1992), 40–44.
20. Han, D.K., Khaing, Z.Z., Pollock, R.A., Haudenschild, C.C., Liau, G., H19, a marker of developmental transition, is reexpressed in human atherosclerotic plaques and is regulated by the insulin family of growth factors in cultured rabbit smooth muscle cells. J. Clin. Investig. 97 (1996), 1276–1285.
21. Han, D., Wang, M., Ma, N., Xu, Y., Jiang, Y., Gao, X., Long noncoding RNAs: novel players in colorectal cancer. Cancer Lett. 361 (2015), 13–21.
22. Zhou, B.P., Hung, M.C., Novel targets of Akt, p21(Cipl/WAF1), and MDM2. Semin. Oncol. 29 (2002), 62–70.
23. Li, J., Zhang, M., Wang, M., Wang, Z., Liu, Y., Zhang, W., Wang, N., GHSR deficiency suppresses neointimal formation in injured mouse arteries. Biochem. Biophys. Res. Commun. 479 (2016), 125–131.
24. Horita, H., Wysoczynski, C.L., Walker, L.A., Moulton, K.S., Li, M., Ostriker, A., Tucker, R., McKinsey, T.A., Churchill, M.E., Nemenoff, R.A., Weiser-Evans, M.C., Nuclear PTEN functions as an essential regulator of SRF-dependent transcription to control smooth muscle differentiation. Nat. Commun., 7, 2016, 10830.
25. Koide, S., Okazaki, M., Tamura, M., Ozumi, K., Takatsu, H., Kamezaki, F., Tanimoto, A., Tasaki, H., Sasaguri, Y., Nakashima, Y., Otsuji, Y., PTEN reduces cuff-induced neointima formation and proinflammatory cytokines. Am. J. Physiol. Heart Circ. Physiol. 292 (2007), H2824–H2831.
26. Nemenoff, R.A., Horita, H., Ostriker, A.C., Furgeson, S.B., Simpson, P.A., VanPutten, V., Crossno, J., Offermanns, S., Weiser-Evans, M.C., SDF-1alpha induction in mature smooth muscle cells by inactivation of PTEN is a critical mediator of exacerbated injury-induced neointima formation. Arterioscler. Thromb. Vasc. Biol. 31 (2011), 1300–1308.
27. Moon, S.-K., Kim, H.-M., Kim, C.-H., PTEN induces G1 cell cycle arrest and inhibits MMP-9 expression via the regulation of NF-κB and AP-1 in vascular smooth muscle cells. Arch. Biochem. Biophy. 421 (2004), 267–276.
28. Huang, J., Niu, X.L., Pippen, A.M., Annex, B.H., Kontos, C.D., Adenovirus-mediated intraarterial delivery of PTEN inhibits neointimal hyperplasia. Arterioscler. Thromb. Vasc. Biol. 25 (2005), 354–358.
29. Mitra, A.K., Jia, G., Gangahar, D.M., Agrawal, D.K., Temporal PTEN inactivation causes proliferation of saphenous vein smooth muscle cells of human CABG conduits. J. Cell Mol. Med. 13 (2009), 177–187.
30. Furgeson, S.B., Simpson, P.A., Park, I., Vanputten, V., Horita, H., Kontos, C.D., Nemenoff, R.A., Weiser-Evans, M.C., Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation. Cardiovasc Res. 86 (2010), 274–282.
31. Zhang, K., Luo, Z., Zhang, Y., Zhang, L., Wu, L., Liu, L., Yang, J., Song, X., Liu, J., Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer. Cancer Biomark. 17 (2016), 187–194.
32. Deng, L., Bradshaw, A.C., Baker, A.H., Role of noncoding RNA in vascular remodelling. Curr. Opin. Lipidol. 27 (2016), 439–448.